{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:23:44Z","timestamp":1791156224549,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015537","name":"Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mayocp.2021.07.024","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T02:48:45Z","timestamp":1638845325000},"page":"294-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-3556","authenticated-orcid":false,"given":"Surendra","family":"Dasari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy C.","family":"Kohlhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.V.","family":"Willrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-9434","authenticated-orcid":false,"given":"Taxiarchis V.","family":"Kourelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-4580","authenticated-orcid":false,"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mayocp.2021.07.024_bib1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.mayocp.2021.07.024_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymeth.2015.04.020","article-title":"Detecting monoclonal immunoglobulins in human serum using mass spectrometry","volume":"81","author":"Mills","year":"2015","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.mayocp.2021.07.024_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/hvz041","article-title":"Mass spectrometry for identification, monitoring, and minimal residual disease detection of M-proteins","volume":"66","author":"Zajec","year":"2020","journal-title":"Clin Chem"},{"issue":"9-10","key":"10.1016\/j.mayocp.2021.07.024_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/prca.201300077","article-title":"Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients","volume":"8","author":"Remily-Wood","year":"2014","journal-title":"Proteomics Clin Appl"},{"issue":"3","key":"10.1016\/j.mayocp.2021.07.024_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/pr400985k","article-title":"Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy","volume":"13","author":"Barnidge","year":"2014","journal-title":"J\u00a0Proteome Res"},{"issue":"21","key":"10.1016\/j.mayocp.2021.07.024_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rcm.7314","article-title":"Using matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobuli light chains in serum and urine","volume":"29","author":"Barnidge","year":"2015","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"10","key":"10.1016\/j.mayocp.2021.07.024_bib7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1373\/clinchem.2015.253740","article-title":"Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI-TOF mass spectrometry","volume":"62","author":"Mills","year":"2016","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.mayocp.2021.07.024_bib8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1373\/clinchem.2015.253781","article-title":"Screening method for M-proteins in serum using nanobody enrichment coupled to MALDI-TOF mass spectrometry","volume":"62","author":"Kohlhagen","year":"2016","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.mayocp.2021.07.024_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41375-018-0194-x","article-title":"Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients","volume":"33","author":"Kumar","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.mayocp.2021.07.024_bib10","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1002\/ajh.25843","article-title":"Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease","volume":"95","author":"Sidana","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.mayocp.2021.07.024_bib11","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41375-020-0940-8","article-title":"N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression","volume":"34","author":"Dispenzieri","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.mayocp.2021.07.024_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/cclm-2020-0581","article-title":"Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab","volume":"59","author":"Kohlhagen","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10.1016\/j.mayocp.2021.07.024_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.24772","article-title":"The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic","volume":"92","author":"Milani","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.07.024_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.mayocp.2021.07.024_bib15","unstructured":"Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act. In: Services USDoHaH, ed2016."},{"issue":"18","key":"10.1016\/j.mayocp.2021.07.024_bib16","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mayocp.2021.07.024_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cancers12010015","article-title":"Therapeutic monoclonal antibodies and antibody products: current practices and development in multiple myeloma","volume":"12","author":"Bonello","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.mayocp.2021.07.024_bib18","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2016-05-636357","article-title":"The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies","volume":"128","author":"Hoyos","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2021.07.024_bib19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2015.223","article-title":"Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives","volume":"30","author":"Lonial","year":"2016","journal-title":"Leukemia"},{"issue":"9727","key":"10.1016\/j.mayocp.2021.07.024_bib20","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mayocp.2021.07.024_bib21","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1038\/bcj.2017.75","article-title":"High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma","volume":"7","author":"Mills","year":"2017","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.mayocp.2021.07.024_bib22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/blood-2018-05-848986","article-title":"A\u00a0universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference","volume":"132","author":"Mills","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mayocp.2021.07.024_bib23","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1002\/ajh.25244","article-title":"MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms","volume":"93","author":"Kourelis","year":"2018","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.07.024_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-021-00444-0","article-title":"MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients","volume":"11","author":"Mellors","year":"2021","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.mayocp.2021.07.024_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1373\/clinchem.2018.299461","article-title":"Direct detection of monoclonal free light chains in serum by use of immunoenrichment-coupled MALDI-TOF mass spectrometry","volume":"65","author":"Sepiashvili","year":"2019","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.mayocp.2021.07.024_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2021.07.024_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.mayocp.2021.07.024_bib28","first-page":"421","article-title":"Identification of friend or foe: the laboratory challenge of differentiating M-proteins from monoclonal antibody therapies","volume":"1","author":"Mills","year":"2017","journal-title":"J\u00a0Appl Lab Med"},{"key":"10.1016\/j.mayocp.2021.07.024_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clinbiochem.2021.02.011","article-title":"Clearing drug interferences in myeloma treatment using mass spectrometry","volume":"92","author":"Kohlhagen","year":"2021","journal-title":"Clin Biochem"},{"issue":"24","key":"10.1016\/j.mayocp.2021.07.024_bib30","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood-2016-09-692947","article-title":"Next-generation multiple myeloma treatment: a pharmacoeconomic perspective","volume":"128","author":"Rajkumar","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mayocp.2021.07.024_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-021-00418-2","article-title":"Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation","volume":"11","author":"Derman","year":"2021","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.mayocp.2021.07.024_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmoldx.2020.04.002","article-title":"Mass spectrometry-based method targeting Ig variable regions for assessment of minimal residual disease in multiple myeloma","volume":"22","author":"Martins","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.mayocp.2021.07.024_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1373\/clinchem.2015.242651","article-title":"Clonotypic light chain peptides identified for monitoring minimal residual disease in multiple myeloma without bone marrow aspiration","volume":"62","author":"Bergen","year":"2016","journal-title":"Clin Chem"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2021.07.024_bib34","first-page":"S37","article-title":"Predictive value of hypogammaglobulinemia in monoclonal gammopathies detected by reflex immunofixation of serum protein electrophoresis samples","volume":"146","author":"Manthei","year":"2016","journal-title":"Am J Clin Pathol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621006522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621006522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:38:24Z","timestamp":1758418704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621006522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0025619621006522"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.07.024","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}